Dolphin Medical Services Ltd.
Snapshot View

3.52 +0.16 ▲4.8%

29 July 2021, 04:00:00 P.M.
Volume: 89,278

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.dolphinmedicalindia.com
Financial Indicators
Market Cap 5.32 Cr.
Earnings per share (EPS) -0.21 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2021-03
Industry PE 228.60 Trailing Twelve Months Ending 2021-03
Book Value / Share 6.95 Trailing Twelve Months Ending 2021-03
Price to Book Value 0.51 Calculated using Price: 3.52
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 1.51 Cr. 15,099,952 Shares
FaceValue 10
Company Profile

Dolphin Medical Services Ltd. is an organization promoted by the doctors of the region. The chief promoters are Dr. M S S Koteswara Rao, an eminent physician and former Minister for health in Andhra Pradesh and Dr. G V Mohan Prasad, a radiologist cum ENT specialist who is also the Managing Director of the company. Dolphin was founded with a lofty ideal of providing quality medical services to improve the quality of life of the people through better health, in the last decade of the the 20th century by renowned medical technologists.

The company provides comprehensive Diagnostic Services since 1994, with a range of tests covering radiology and imaging, biochemistry, pathology and microbiology, etc., to the people of the coastal region of Andhra Pradesh.

The maiden venture of the group started at Visakhapatnam providing medical diagnostic services ranging from simple laboratory test to the complex whole body CT scanning under one roof thus saving the time and energy of the patients and assuring them accurate and prompt services.

Later, the group extended its activities to Vijayawada, a commercial, educational and medical centre of the coastal Andhra Pradesh and established a diagnostic centre with the most sophisticated and state-of-the-art equipment.The group turned a new leaf in providing diagnostic services in the medical field. Subsequently, the group opened an eye-care laser centre, the first of its kind unit in the entire coastal Andhra Pradesh. The eye-care laser centre is equipped with the ultra-modern laser equipment to provide readily available and highly reliable services to the patients of ophthalmic problems.

The company was able to withstand the tough competition in the market and still enhance the profitability of the company. The present status of the company is that the it is debt free and is profit making for the past three years with the profits increasing year after year. In addition it has also the eye care division called the “Dolphin Nethralaya” which is a comprehensive eye care and laser and research centre.The company has also ventured in to IT and biotechnology and Herbal sectors but attained only limited progress in these sectors due to some inherent constraints.

Services offered by the company:

  • Dolphin Medical Services
  • Dolphin Nethralaya
  • Dolphin Electronic Solutions and Technologies(D.E.S.T)
  • Dolphin Biotech Health Foods & Herbals

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+4.76%
1 Week
-5.38%
1 Month
-24.14%
3 Month
+45.45%
6 Month
+122.78%
1 Year
+144.44%
2 Year
+214.29%
5 Year
+314.12%
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) -8.78 -12.99 -6.26 -4.39 -0.36 -2.12 -2.41 -8.60 -3.50
Return on Capital Employed (%) -1.07 -5.35 -3.68 -2.56 -0.06 -1.43 -1.57 -5.38 -2.07
Return on Assets (%) -5.94 -8.26 -3.80 -2.62 -0.21 -1.25 -1.41 -5.15 -2.15

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 16 14 13 13 13 12 12 11 11
Non Curr. Liab. 8 9 9 9 9 9 9 7 7
Curr. Liab. 0 0 0 0 0 0 0 0 0
Minority Int.
Equity & Liab. 25 23 22 22 22 21 21 18 18
Non Curr. Assets 22 21 21 20 20 19 19 16 16
Curr. Assets 3 2 2 2 2 2 2 2 2
Misc. Exp. not W/O
Total Assets 25 23 22 22 22 21 21 18 18

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 4 1 1 0 1 0 0 0 0
Other Income 0 0 0 0 0 0
Total Income 4 1 1 0 1 0 0 0 0
Total Expenditure -3 -2 -1 0 0 0 0 -1 -1
PBIDT 0 -1 0 0 0 0 0 -1 0
Interest -1 -1 0 0 0 0 0 0 0
Depreciation -1 -1 -1 -1 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0
Exceptional Items
PAT -1 -2 -1 -1 0 0 0 -1 0

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 1 0 0 0 0 0 0 0
Cash Fr. Inv. -1 0 0 0 0 2 0
Cash Fr. Finan. -1 0 0 0 0 0 -2 0
Net Change 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 26.44 26.44 26.44 26.44 26.44 26.44 26.44 26.44 26.44
Public 73.56 73.56 73.56 73.56 73.56 73.56 73.56 73.56 73.56
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Tue, 20 Jul 2021
Shareholding for the Period Ended June 30 2021
Dolphin Medical Services Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30 2021. For more details kindly Click here
Mon, 12 Jul 2021
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Compliance Certificate under Regulation 74(5) of SEBI (LODR) Regulations
Mon, 12 Jul 2021
Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0000
Name of the Signatory :- Dr MOHAN PRASAD GV
Designation :- Managing Director / Whole Time Director

Technical Scans View Details

Thu, 29 Jul 2021
Both SRS And ARS Above Zero Both SRS And ARS Above Zero
PSAR Indicating Bearish Reversal PSAR Indicating Bearish Reversal
Wed, 28 Jul 2021
Decreasing Relative Strength - Benchmark index Decreasing Relative Strength - Benchmark index
Decreasing Relative Strength - Sectoral index Decreasing Relative Strength - Sectoral index
Both SRS And ARS Above Zero Both SRS And ARS Above Zero

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 168,733.23 703.00 +2.2%
Divi's Laboratories Ltd. 128,656.69 4,843.80 -1.0%
Dr. Reddy's Laboratories Ltd. 77,707.65 4,672.65 -1.2%
Cipla Ltd. 71,170.06 883.10 -0.8%
Cadila Healthcare Ltd. 58,547.84 572.00 -0.9%
Apollo Hospitals Enterprise Ltd. 58,067.43 4,028.55 0.0%
Aurobindo Pharma Ltd. 53,214.94 908.25 -0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 58.11 703.00 +2.2%
Divi's Laboratories Ltd. Consolidated 2021-03 64.84 4,843.80 -1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 44.73 4,672.65 -1.2%
Cipla Ltd. Consolidated 2021-03 29.59 883.10 -0.8%
Cadila Healthcare Ltd. Consolidated 2021-03 27.44 572.00 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 386.19 4,028.55 0.0%
Aurobindo Pharma Ltd. Consolidated 2021-03 9.98 908.25 -0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 3.63 703.00 +2.2%
Divi's Laboratories Ltd. Consolidated 2021-03 13.84 4,843.80 -1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 4.35 4,672.65 -1.2%
Cipla Ltd. Consolidated 2021-03 3.88 883.10 -0.8%
Cadila Healthcare Ltd. Consolidated 2021-03 4.51 572.00 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.64 4,028.55 0.0%
Aurobindo Pharma Ltd. Consolidated 2021-03 2.43 908.25 -0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 703.00 +2.2%
Divi's Laboratories Ltd. Consolidated 2020-03 0.00 4,843.80 -1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,672.65 -1.2%
Cipla Ltd. Consolidated 2020-03 0.18 883.10 -0.8%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 572.00 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 4,028.55 0.0%
Aurobindo Pharma Ltd. Consolidated 2020-03 0.33 908.25 -0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 703.00 +2.2%
Divi's Laboratories Ltd. Consolidated 2020-03 19.30 4,843.80 -1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,672.65 -1.2%
Cipla Ltd. Consolidated 2020-03 10.09 883.10 -0.8%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 572.00 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 4,028.55 0.0%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.53 908.25 -0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 703.00 +2.2%
Divi's Laboratories Ltd. Consolidated 2020-03 25.36 4,843.80 -1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 4,672.65 -1.2%
Cipla Ltd. Consolidated 2020-03 12.53 883.10 -0.8%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 572.00 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 4,028.55 0.0%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.80 908.25 -0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 703.00 +2.2%
Divi's Laboratories Ltd. Consolidated 2020-03 5,394.42 4,843.80 -1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,672.65 -1.2%
Cipla Ltd. Consolidated 2020-03 17,131.99 883.10 -0.8%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 572.00 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 4,028.55 0.0%
Aurobindo Pharma Ltd. Consolidated 2020-03 23,098.51 908.25 -0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 703.00 +2.2%
Divi's Laboratories Ltd. Consolidated 2020-03 1,376.54 4,843.80 -1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,672.65 -1.2%
Cipla Ltd. Consolidated 2020-03 1,546.98 883.10 -0.8%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 572.00 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 4,028.55 0.0%
Aurobindo Pharma Ltd. Consolidated 2020-03 2,844.69 908.25 -0.8%